FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (A A H Pharmaceuticals Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (Alliance Healthcare (Distribution) Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Ennogen Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (Ennogen Healthcare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Ennogen Healthcare Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (Ennogen Healthcare Ltd) 60 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Vitasavoury Starter Pack powder - invalid VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Vitasavoury Starter Pack powder - invalid VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Vitasavoury Starter Pack powder - invalid 400 gram VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Vitasavoury Starter Pack powder - invalid 332 gram VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Vitasavoury Starter Pack powder - invalid (Vitaflo International Ltd) 332 gram 1x(4x33g pots+4x50g sachets) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Vitasavoury Starter Pack powder - invalid (Vitaflo International Ltd) 400 gram 1 x (4 x (2 x 50g) sachets) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atrauman Silicone dressing 7.5cm x 10cm (Paul Hartmann Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atrauman Silicone dressing 20cm x 30cm (Paul Hartmann Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amoxapine 100mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amoxapine 100mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atrauman Silicone dressing 7.5cm x 10cm (Paul Hartmann Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atrauman Silicone dressing 7.5cm x 10cm (Paul Hartmann Ltd) 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atrauman Silicone dressing 20cm x 30cm (Paul Hartmann Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atrauman Silicone dressing 20cm x 30cm (Paul Hartmann Ltd) 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amoxapine 100mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nurofen Max Strength Joint & Back Pain Relief 512mg tablets (Reckitt Benckiser Healthcare (UK) Ltd) 24 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ispaghula husk 3.5g granules sachets gluten free (Colorama Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ispaghula husk 3.5g granules sachets gluten free (Colorama Pharmaceuticals Ltd) 30 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-danthrusate 50mg/60mg/5ml oral suspension sugar free (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-danthrusate 50mg/60mg/5ml oral suspension sugar free (Pinewood Healthcare) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Normax suspension (Celltech Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-danthrusate 50mg/60mg/5ml oral suspension sugar free 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Normax suspension (Celltech Pharmaceuticals Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-danthrusate 50mg/60mg/5ml oral suspension sugar free (A A H Pharmaceuticals Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-danthrusate 50mg/60mg/5ml oral suspension sugar free (Pinewood Healthcare) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1mL injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Haldol 5mg/1ml solution for injection ampoules (Lexon (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Serenace 5mg/1ml solution for injection ampoules (IVAX Pharmaceuticals UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haldol 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules (Goldshield Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haldol 5mg/1ml solution for injection ampoules (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haldol 5mg/1ml solution for injection ampoules (Lexon (UK) Ltd) 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 1ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haldol 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 5 ampoule 5 x 1ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules (Goldshield Pharmaceuticals Ltd) 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haldol 5mg/1ml solution for injection ampoules (Mawdsley-Brooks & Company Ltd) 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Serenace 5mg/1ml solution for injection ampoules (IVAX Pharmaceuticals UK Ltd) 10 ampoule 10 x 1ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules (Unichem Plc) 10 ampoule 10 x 1ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules (Special Order) 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 40micrograms/activation iontophoretic transdermal system VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ionsys 40micrograms/dose transdermal system (The Medicines Company UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 40micrograms/dose transdermal system 1 system VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ionsys 40micrograms/dose iontophoretic transdermal system (Janssen-Cilag Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 40micrograms/dose transdermal system 6 system VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ionsys 40micrograms/dose transdermal system (The Medicines Company UK Ltd) 6 system VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ionsys 40micrograms/dose iontophoretic transdermal system (Janssen-Cilag Ltd) 1 system 80 doses VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
UrgoStart Border dressing 15cm x 20cm (Urgo Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Silver nitrate 40% caustic pencils (Colorama Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Brown & Burk UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 1.25mg capsules (Brown & Burk UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 2.5mg capsules (Brown & Burk UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 5mg capsules (Brown & Burk UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
UrgoStart Border dressing 15cm x 20cm (Urgo Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
UrgoStart Border dressing 15cm x 20cm (Urgo Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Silver nitrate 40% caustic pencils (Colorama Pharmaceuticals Ltd) 1 applicator VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Brown & Burk UK Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 1.25mg capsules (Brown & Burk UK Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 2.5mg capsules (Brown & Burk UK Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 5mg capsules (Brown & Burk UK Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-trimoxazole 40mg/200mg/5mL pediatric s/f suspension VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 5 milligram/1 gram conventional release eye ointment VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrocortisone 0.5% eye ointment 3 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrocortisone 0.5% eye ointment (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free (Aspen Pharma Trading Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrocortisone 0.5% eye ointment (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrocortisone 0.5% eye ointment (Martindale Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrocortisone 0.5% eye ointment 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrocortisone 0.5% eye ointment (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Septrin Paediatric suspension (GlaxoSmithKline) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrocortisone 0.5% eye ointment (A A H Pharmaceuticals Ltd) 3 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free (Aspen Pharma Trading Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrocortisone 0.5% eye ointment (Unichem Plc) 3 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Septrin Paediatric suspension (GlaxoSmithKline) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrocortisone 0.5% eye ointment (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrocortisone 0.5% eye ointment (Martindale Pharmaceuticals Ltd) 3 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nabilone 1mg capsules (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free (A A H Pharmaceuticals Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free (Alliance Healthcare (Distribution) Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nabilone 1mg capsules (Alliance Healthcare (Distribution) Ltd) 20 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 500micrograms/5ml solution for injection pre-filled syringes (Aguettant Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Almus Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 500micrograms/5ml solution for injection pre-filled syringes (Aguettant Ltd) 1 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 68 of 86 Next End

This concept is not in any reference sets

Back to Start